Neoplasms, Germ Cell and Embryonal  >>  Signifor LAR (pasireotide long acting release)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Signifor LAR (pasireotide long acting release) / Recordati
COOPERATE-1, NCT01374451 / 2010-023183-40: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

Terminated
2
160
Japan, US, Canada, Europe, RoW
Everolimus, RAD001, Pasireotide LAR, SOM230 LAR
Novartis Pharmaceuticals
Islet Cell Tumor
02/15
02/15

Download Options